RARE
$14.54-4.15%
Ultragenyx Pharmaceutical Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.007%US Stock Market 0.004%Russell 3000 0.004%
Ultragenyx Pharmaceutical Inc. monthly returns
Ultragenyx Pharmaceutical Inc. has averaged 0.63% per month, positive in 47% of months. Month-by-month returns for Ultragenyx Pharmaceutical Inc. (RARE) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+0.6%
142 months
Best month
+54.2%
May 2015
Worst month
-49.9%
Jan 2016
Positive months
47%
of all months
Ultragenyx Pharmaceutical Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -3.3% | |
| Sep 2026 | -40.4% | |
| Aug 2026 | +1.2% | |
| Jul 2026 | -25.4% | |
| Jun 2026 | +39.5% | |
| May 2026 | -3.0% | |
| Apr 2026 | +17.9% | |
| Mar 2026 | -10.4% | |
| Feb 2026 | -2.8% | |
| Jan 2026 | +4.7% | |
| Dec 2025 | -33.8% | |
| Nov 2025 | +0.4% | |
| Oct 2025 | +15.0% | |
| Sep 2025 | +0.4% | |
| Aug 2025 | +9.7% | |
| Jul 2025 | -24.9% | |
| Jun 2025 | +6.8% | |
| May 2025 | -12.7% | |
| Apr 2025 | +7.6% | |
| Mar 2025 | -15.6% | |
| Feb 2025 | -0.3% | |
| Jan 2025 | +2.3% | |
| Dec 2024 | -11.7% | |
| Nov 2024 | -6.6% | |
| Oct 2024 | -8.2% | |
| Sep 2024 | -2.2% | |
| Aug 2024 | +26.1% | |
| Jul 2024 | +9.5% | |
| Jun 2024 | +2.4% | |
| May 2024 | -5.6% | |
| Apr 2024 | -8.9% | |
| Mar 2024 | -9.7% | |
| Feb 2024 | +17.3% | |
| Jan 2024 | -7.8% | |
| Dec 2023 | +23.1% | |
| Nov 2023 | +9.7% | |
| Oct 2023 | -0.7% | |
| Sep 2023 | -3.1% | |
| Aug 2023 | -14.7% | |
| Jul 2023 | -6.5% | |
| Jun 2023 | -6.5% | |
| May 2023 | +13.0% | |
| Apr 2023 | +8.9% | |
| Mar 2023 | -9.9% | |
| Feb 2023 | -1.9% | |
| Jan 2023 | -2.2% | |
| Dec 2022 | +27.6% | |
| Nov 2022 | -10.3% | |
| Oct 2022 | -2.3% | |
| Sep 2022 | -13.2% | |
| Aug 2022 | -10.5% | |
| Jul 2022 | -10.7% | |
| Jun 2022 | +27.2% | |
| May 2022 | -33.7% | |
| Apr 2022 | -2.7% | |
| Mar 2022 | +7.9% | |
| Feb 2022 | -3.7% | |
| Jan 2022 | -16.8% | |
| Dec 2021 | +11.8% | |
| Nov 2021 | -10.4% | |
| Oct 2021 | -7.0% | |
| Sep 2021 | -6.3% | |
| Aug 2021 | +20.6% | |
| Jul 2021 | -16.3% | |
| Jun 2021 | -6.3% | |
| May 2021 | -8.9% | |
| Apr 2021 | -1.9% | |
| Mar 2021 | -19.6% | |
| Feb 2021 | +2.1% | |
| Jan 2021 | +0.1% | |
| Dec 2020 | +16.8% | |
| Nov 2020 | +18.0% | |
| Oct 2020 | +22.3% | |
| Sep 2020 | -3.4% | |
| Aug 2020 | +8.8% | |
| Jul 2020 | -0.1% | |
| Jun 2020 | +14.3% | |
| May 2020 | +13.3% | |
| Apr 2020 | +36.0% | |
| Mar 2020 | -20.8% | |
| Feb 2020 | +6.7% | |
| Jan 2020 | +23.0% | |
| Dec 2019 | +7.7% | |
| Nov 2019 | -1.2% | |
| Oct 2019 | -6.2% | |
| Sep 2019 | -21.5% | |
| Aug 2019 | -9.6% | |
| Jul 2019 | -5.1% | |
| Jun 2019 | +15.6% | |
| May 2019 | -16.8% | |
| Apr 2019 | -4.8% | |
| Mar 2019 | +8.1% | |
| Feb 2019 | +30.0% | |
| Jan 2019 | +13.4% | |
| Dec 2018 | -19.0% | |
| Nov 2018 | +10.8% | |
| Oct 2018 | -36.5% | |
| Sep 2018 | -9.9% | |
| Aug 2018 | +7.1% | |
| Jul 2018 | +2.9% | |
| Jun 2018 | +5.0% | |
| May 2018 | +44.0% | |
| Apr 2018 | -0.3% | |
| Mar 2018 | +6.7% | |
| Feb 2018 | -10.4% | |
| Jan 2018 | +15.0% | |
| Dec 2017 | -8.1% | |
| Nov 2017 | +9.5% | |
| Oct 2017 | -13.5% | |
| Sep 2017 | -6.7% | |
| Aug 2017 | -14.0% | |
| Jul 2017 | +6.8% | |
| Jun 2017 | +15.3% | |
| May 2017 | -16.4% | |
| Apr 2017 | -5.0% | |
| Mar 2017 | -20.3% | |
| Feb 2017 | +13.4% | |
| Jan 2017 | +6.7% | |
| Dec 2016 | -10.2% | |
| Nov 2016 | +32.7% |
Monthly total return (since Nov 2021)#
-40%-20%0%20%40%
Nov 2021-10%
Dec 2021+12%
Jan 2022-17%2022
Feb 2022-3.7%
Mar 2022+7.9%
Apr 2022-2.7%
May 2022-34%
Jun 2022+27%
Jul 2022-11%
Aug 2022-10%
Sep 2022-13%
Oct 2022-2.3%
Nov 2022-10%
Dec 2022+28%
Jan 2023-2.2%2023
Feb 2023-1.9%
Mar 2023-9.9%
Apr 2023+8.9%
May 2023+13%
Jun 2023-6.5%
Jul 2023-6.5%
Aug 2023-15%
Sep 2023-3.1%
Oct 2023-0.7%
Nov 2023+9.7%
Dec 2023+23%
Jan 2024-7.8%2024
Feb 2024+17%
Mar 2024-9.7%
Apr 2024-8.9%
May 2024-5.6%
Jun 2024+2.4%
Jul 2024+9.5%
Aug 2024+26%
Sep 2024-2.2%
Oct 2024-8.2%
Nov 2024-6.6%
Dec 2024-12%
Jan 2025+2.3%2025
Feb 2025-0.26%
Mar 2025-16%
Apr 2025+7.6%
May 2025-13%
Jun 2025+6.8%
Jul 2025-25%
Aug 2025+9.7%
Sep 2025+0.4%
Oct 2025+15%
Nov 2025+0.43%
Dec 2025-34%
Jan 2026+4.7%2026
Feb 2026-2.8%
Mar 2026-10%
Apr 2026+18%
May 2026-3.0%
Jun 2026+39%
Jul 2026-25%
Aug 2026+1.2%
Sep 2026-40%
Oct 2026-3.3%
Ultragenyx Pharmaceutical Inc. returns by calendar month#
Every month of every year since 2015, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -3.26% — 6th of 12 Octobers since 2015 at the last close; the average October returned -4.6%.
| Month | −55%0+55% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +1.7% | +3.5% | 67% | +32.4% 2015 | -49.9% 2016 | |
| Feb | +4.4% | +0.9% | 50% | +30.0% 2019 | -10.4% 2018 | |
| Mar | -5.5% | -9.8% | 42% | +14.4% 2015 | -20.8% 2020 | |
| Apr | +3.7% | -1.1% | 42% | +36.0% 2020 | -9.1% 2015 | |
| May | +3.0% | -4.3% | 42% | +54.2% 2015 | -33.7% 2022 | |
| Jun | +8.2% | +10.6% | 75% | +39.5% 2026 | -33.1% 2016 | |
| Jul | -1.9% | -2.6% | 42% | +29.4% 2016 | -25.4% 2026 | |
| Aug | +1.8% | +2.7% | 58% | +26.1% 2024 | -14.7% 2023 | |
| Sep | -9.4% | -6.5% | 17% | +7.6% 2016 | -40.4% 2026 | |
| Oct | -4.6% | -6.2% | 27% | +22.3% 2020 | -36.5% 2018 | |
| Nov | +4.7% | +0.4% | 55% | +32.7% 2016 | -10.4% 2021 | |
| Dec | +1.7% | +7.7% | 55% | +27.6% 2022 | -33.8% 2025 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from RARE's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Ultragenyx Pharmaceutical Inc.'s average monthly return?
- Ultragenyx Pharmaceutical Inc. (RARE) has averaged about 0.63% per month, positive in roughly 47% of months. The best month was May 2015 (+54.2%) and the worst was Jan 2016 (-49.9%).
More on Ultragenyx Pharmaceutical Inc.
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100